ATE261125T1 - Erkennung von tmorspezifische genprodukte - Google Patents

Erkennung von tmorspezifische genprodukte

Info

Publication number
ATE261125T1
ATE261125T1 AT98924666T AT98924666T ATE261125T1 AT E261125 T1 ATE261125 T1 AT E261125T1 AT 98924666 T AT98924666 T AT 98924666T AT 98924666 T AT98924666 T AT 98924666T AT E261125 T1 ATE261125 T1 AT E261125T1
Authority
AT
Austria
Prior art keywords
detection
specific gene
gene products
tmo
chromosomal aberrations
Prior art date
Application number
AT98924666T
Other languages
English (en)
Inventor
Paulus Benjamin Berendes
Janine Nicole Veenman
Denderen Adriana Cornelia Van
Ewijk Willem Van
Original Assignee
Univ Erasmus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus filed Critical Univ Erasmus
Application granted granted Critical
Publication of ATE261125T1 publication Critical patent/ATE261125T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98924666T 1997-05-20 1998-05-20 Erkennung von tmorspezifische genprodukte ATE261125T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201507 1997-05-20
PCT/NL1998/000289 WO1998053317A1 (en) 1997-05-20 1998-05-20 Recognition of tumour-specific gene products in cancer

Publications (1)

Publication Number Publication Date
ATE261125T1 true ATE261125T1 (de) 2004-03-15

Family

ID=8228328

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98924666T ATE261125T1 (de) 1997-05-20 1998-05-20 Erkennung von tmorspezifische genprodukte

Country Status (10)

Country Link
US (1) US6610498B1 (de)
EP (1) EP0983510B1 (de)
AT (1) ATE261125T1 (de)
AU (1) AU7677198A (de)
CA (1) CA2290656C (de)
DE (1) DE69822149T2 (de)
DK (1) DK0983510T3 (de)
ES (1) ES2217558T3 (de)
PT (1) PT983510E (de)
WO (1) WO1998053317A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0878552A1 (de) 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molekularer Nachweis von chromosomalen Veränderungen
US6686165B2 (en) * 1997-05-20 2004-02-03 Erasmus Universiteit Rotterdam Recognition of tumor-specific gene products in cancer
AU3516899A (en) 1998-05-04 1999-11-23 Dako A/S Method and probes for the detection of chromosome aberrations
WO2002044719A1 (en) * 2000-11-29 2002-06-06 Statens Serum Institut A screening assay for detecting chromosome rearrangements or recombinations
CA2505509C (en) 2002-11-07 2013-08-20 Erasmus Universiteit Rotterdam Method and probes for the detection of a tumor specific fusion protein
EP1507147A1 (de) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein
US7242330B2 (en) * 2003-12-17 2007-07-10 Texas Instruments Incorporated Dynamic compensation of analog-to-digital converter (ADC) offset errors using filtered PWM
US20050214301A1 (en) * 2004-03-24 2005-09-29 Cell Signaling Technology, Inc. Antibodies specific for BCR-ABL fusion protein and uses thereof
WO2007061684A1 (en) * 2005-11-18 2007-05-31 Board Of Regents, The University Of Texas System Quantification of fusion proteins and their activity from chromosomal translocation
MX337666B (es) * 2009-10-20 2016-03-14 Nestec Sa Ensayos regulados mediante proximidad para detectar proteinas de fusion oncogenicas.
US20120065092A1 (en) 2010-09-14 2012-03-15 Wai Hobert Fusion analyte cytometric bead assay, and systems and kits for performing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083709A (en) * 1985-08-21 2000-07-04 Osi Pharmaceuticals, Inc. Immunoassay for detection of mutant P53 polypeptide in serum
US5447837A (en) * 1987-08-05 1995-09-05 Calypte, Inc. Multi-immunoassay diagnostic system for antigens or antibodies or both
WO1991007489A1 (en) * 1989-11-22 1991-05-30 Childrens Hospital Of Los Angeles Bcr/abl transgenic animals as models for philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia
WO1992000311A1 (en) * 1990-06-27 1992-01-09 Princeton University Probes for detecting mutant p53
WO1992021032A1 (en) * 1991-05-24 1992-11-26 The Regents Of The University Of California Methods for the detection of bcr-abl and abnormal abl proteins in leukemia patients
JPH07502164A (ja) * 1991-09-20 1995-03-09 フレッド ハッチンソン キャンサー リサーチ センター ヒトサイクリンｅ
FR2691475B1 (fr) * 1992-05-20 1995-03-24 Centre Nat Rech Scient Séquence d'ADN des produits de fusion résultant de la translocation chromosomique récurrente t(11;22) (q24;q12) associée au développement d'un groupe de tumeurs cancéreuses.
US5667981A (en) * 1994-05-13 1997-09-16 Childrens Hospital Of Los Angeles Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein
DE4444969C1 (de) * 1994-12-16 1996-10-24 Orga Med Dr Med Erwin Klopfer Nachweis von Antikörpern gegen p53 in Körperflüssigkeiten
US6150110A (en) * 1998-02-28 2000-11-21 The Brigham And Women's Hospital, Inc. HMGI(Y)-LAMA4* fusion oncogene, oncoprotein and methods of use

Also Published As

Publication number Publication date
DK0983510T3 (da) 2004-07-05
CA2290656C (en) 2008-01-15
AU7677198A (en) 1998-12-11
US6610498B1 (en) 2003-08-26
EP0983510B1 (de) 2004-03-03
EP0983510A1 (de) 2000-03-08
CA2290656A1 (en) 1998-11-26
ES2217558T3 (es) 2004-11-01
DE69822149T2 (de) 2005-03-03
WO1998053317A1 (en) 1998-11-26
DE69822149D1 (de) 2004-04-08
PT983510E (pt) 2004-06-30

Similar Documents

Publication Publication Date Title
Scott et al. A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies
IL138497A0 (en) Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
BR0112385A (pt) Meio de coleta universal
EP1035215A3 (de) Verfahren und Sondenset zur Erkennung von Krebs
ATE445841T1 (de) Verfahren zur spezifischen detektion von tumorzellen und ihren vorstufen in gebärmutterhalsabstrichen durch simultane messung von mindestens 2 verschiedenen molekularen markern
DE69822149D1 (de) Erkennung von tmorspezifische genprodukte
DE69528653D1 (de) Genetische diagnose und pharmazeutische produkte zur behandlung von prostatakrebs
DE69735294D1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
BR9916840A (pt) Sistema de detecção biológica portátil integrado
ATE475097T1 (de) Erkennung von tumor-spezifischen genprodukten bei krebs
Oh et al. Rapid serial immunoprofiling of the tumor immune microenvironment by fine needle sampling
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
Yang et al. Proximity-guaranteed DNA machine for accurate identification of breast cancer extracellular vesicles
EP0780680A3 (de) Analysator zur Analyse von Urinbestandteilen
Gajzer et al. Flow cytometry for B-cell non-Hodgkin and Hodgkin lymphomas
EP0930369A4 (de) Verfahren zum entdecken von telomerase-aktivität
WO2001042503A3 (en) Apparatus and methods for drug screening based on nucleic acid analysis
ATE404676T1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
WO2004041076A3 (en) Methods of detecting colorectal cancer
BR9708256A (pt) Processo para identificar genes com expresão específica ao síto ou de síto preferido em células de marcacção específicas presentes em um ambiente de células diferente ou não daquele de sua origem e uso do mesmo
Hammers et al. Ultraviolet‐induced detection of halogenated pyrimidines: Simultaneous analysis of DNA replication and cellular markers
DK1042349T3 (da) Anvendelse af polyamid-nukleinsyre-oligomerer til frembringelse af et biologisk respons
Holman et al. Detecting exposure to environmental organic toxins in individual cells: toward development of a microfabricated device

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0983510

Country of ref document: EP